MedTrace Logo

Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula

NCT02598817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2023-02-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of term infant formula containing high 2-palmitic vegetable oil on stool composition, stool characteristics and gastrointestinal (GI) Tolerance.

Conditions

  • Infant Term Birth

Interventions

OTHER

Standard Infant Formula

Standard Infant Formula containing High Sn-2

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Islam Tawfiq Al Baroudi, MD · Pediatric Gastroenterologist

Eligibility

Min Age
2 Weeks
Max Age
12 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-01-08
Completion
2021-01-05

Countries

  • Saudi Arabia
  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02598817 on ClinicalTrials.gov